Melanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma.
about
Development and external validation of a prognostic nomogram for metastatic uveal melanomaSignaling Pathways in MelanogenesisThe Development of Sugar-Based Anti-Melanogenic AgentsFusion of bone marrow-derived cells with cancer cells: metastasis as a secondary disease in cancerUveal melanoma cells utilize a novel route for transendothelial migrationWhole Body Melanoma Transcriptome Response in MedakaDecreased VDR expression in cutaneous melanomas as marker of tumor progression: new data and analysesSDHD promoter mutations are rare events in cutaneous melanomas but SDHD protein expression is downregulated in advanced cutaneous melanomaA novel miR-451a isomiR, associated with amelanotypic phenotype, acts as a tumor suppressor in melanoma by retarding cell migration and invasionCYP24A1 expression inversely correlates with melanoma progression: clinic-pathological studies.IL28B polymorphism cannot predict response to interferon alpha treatment in patients with melanoma.P-selectin-mediated platelet adhesion promotes the metastasis of murine melanoma cells.Stage-specific prognostic biomarkers in melanomaAntitumor effects of vitamin D analogs on hamster and mouse melanoma cell lines in relation to melanin pigmentation.Vitamin D deficiency at melanoma diagnosis is associated with higher Breslow thickness.Brucella spp. Lumazine Synthase Induces a TLR4-Mediated Protective Response against B16 Melanoma in Mice.Metastasis suppressor NME1 regulates melanoma cell morphology, self-adhesion and motility via induction of fibronectin expressionHyperpigmentation Results in Aberrant Immune Development in Silky Fowl (Gallus gallus domesticus Brisson)The Effect of Electroporation of a Lyotroic Liquid Crystal Genistein-Based Formulation in the Recovery of Murine Melanoma Lesions.Distribution of GNAQ and GNA11 Mutation Signatures in Uveal Melanoma Points to a Light Dependent Mutation Mechanism.Clinical Characteristics of 582 Patients with Uveal Melanoma in China.Proanthocyanidins Extracted from Rhododendron pulchrum Leaves as Source of Tyrosinase Inhibitors: Structure, Activity, and Mechanism.Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Correlates with Poor Prognosis in Acral Lentiginous Melanoma.Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in MiceCharacterization of the Methylthioadenosine Phosphorylase Polymorphism rs7023954 - Incidence and Effects on Enzymatic Function in Malignant MelanomaPD-1 Antibody Monotherapy for Malignant Melanoma: A Systematic Review and Meta-AnalysisEfficient Percutaneous Delivery of the Antimelanogenic Agent Glabridin Using Cationic Amphiphilic Chitosan MicellesClinical Characteristics of Malignant Melanoma in Southwest China: A Single-Center Series of 82 Consecutive Cases and a Meta-Analysis of 958 Reported CasesDeep-proteome mapping of WM-266-4 human metastatic melanoma cells: From oncogenic addiction to druggable targetsBifunctional effects of O-methylated flavones from Scutellaria baicalensis Georgi on melanocytes: Inhibition of melanin production and intracellular melanosome transportCharacterization of long noncoding RNA and messenger RNA signatures in melanoma tumorigenesis and metastasis.Combined regimen of photodynamic therapy mediated by Gallium phthalocyanine chloride and Metformin enhances anti-melanoma efficacyLoss of tumor suppressors KAI1 and p27 identifies a unique subgroup of primary melanoma patients with poor prognosis.The importance of microenvironment: the role of CCL8 in metastasis formation of melanoma.Melanin content in melanoma metastases affects the outcome of radiotherapy.RORα and RORγ expression inversely correlates with human melanoma progression.The role of CYP11A1 in the production of vitamin D metabolites and their role in the regulation of epidermal functions.Current position of TNF-α in melanomagenesis.Gomisin N Inhibits Melanogenesis through Regulating the PI3K/Akt and MAPK/ERK Signaling Pathways in MelanocytesPeroxisome proliferator-activated receptor α (PPARα) contributes to control of melanogenesis in B16 F10 melanoma cells.
P2860
Q21131800-5DBDB8C2-FC17-4358-A907-6EAC7B6DE6ECQ26739678-1D214D6A-40B5-4307-96E5-CB9EC1227368Q26752370-34519E8A-7F00-494A-BA2C-8105612C180AQ27000378-746E2FAC-9D5E-4E53-AEC5-76411F2342FAQ27319660-17BCB36F-18FE-4B4D-B882-80E46248F313Q28551986-51E744CA-DBC0-44F9-8184-F753C8FDD0A8Q30830686-7E92431C-E21E-429D-8082-326C4675F3CBQ33853615-E7DE8BCC-0AEC-4287-9D4E-1EBB9D877707Q34215802-4DA42F84-5168-4A02-88F6-BE5D81B97FC8Q34487000-943141E7-6179-42FB-8608-0C8E2B006957Q34497983-7989E180-9743-49F9-BF55-8692A7C4D686Q35121768-C5516DA9-E6FC-4388-87A0-CB36C85AB15BQ35551970-F907299A-7746-4DF0-9E4D-59B1305BE92DQ35585386-DD9B5060-9C3B-4F63-A36A-2E9BD6A6DC7AQ35603114-229A7A0D-F866-40F4-BFBC-1DECAD669F0FQ35606746-5C603FF8-35A0-46C2-98A8-4FDEA230FC5FQ35624820-F650BF40-EEDB-455B-A3CF-F7819354F3D5Q35654447-546E66DB-9D89-4D7E-9D94-7CD052129364Q35694032-E7A14447-037B-48E6-A238-0A568EFF5E9EQ35774475-C2E52292-C0B1-48C1-806A-B97FF6FBBA11Q35863197-533877DD-3387-4B13-AD1B-A4BFDCA2F319Q35880470-9F142583-B90B-4D30-9723-42255E0199DEQ35900481-991003B7-26D9-4737-91A6-71D5EE13229FQ36048258-A7CF0E43-5A0D-42AE-825D-8214C7A58407Q36091672-5F567EA5-391C-4149-87D9-12996952D6F7Q36092580-3FEDEDDB-4541-474D-956B-E01B392A59EFQ36151321-5A7728E6-9384-46A8-ACB6-4321613DC2FDQ36197056-DAE56F21-DB46-49ED-A0A2-694D479A0E86Q36270042-D31E5D0D-D08F-42B7-8FFC-BA2225C49C3EQ36275469-0ECEF0DD-8FB5-4D32-B069-2ADF75C7D24FQ36287435-6ABE5C62-FE9D-4B12-818E-E7CB2D1020D7Q36302221-ED1F94C9-CB62-462E-9FF6-5CA0B1AC2DBEQ36356155-F9FDEDB3-5711-4BCA-9168-2EEA8E34EB31Q36557228-321573B5-E40B-441F-B246-5D953F27F5A9Q37109611-922372C3-9B07-47F5-BB79-630EAE74A90DQ37665305-775E29C8-E4EE-486B-AE40-A2C64EE0DE88Q38157408-6371DC76-8EF9-4386-810B-21A9D40B5730Q38567932-0F172B40-2463-412F-8388-48F7C63598FBQ38714668-45855C72-DD4E-45C1-8978-B2B881AF5B1FQ38721499-8D7F6473-9822-43B4-B39A-B80DB761B324
P2860
Melanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Melanogenesis affects overall ...... ith stage III and IV melanoma.
@en
Melanogenesis affects overall ...... ith stage III and IV melanoma.
@nl
type
label
Melanogenesis affects overall ...... ith stage III and IV melanoma.
@en
Melanogenesis affects overall ...... ith stage III and IV melanoma.
@nl
prefLabel
Melanogenesis affects overall ...... ith stage III and IV melanoma.
@en
Melanogenesis affects overall ...... ith stage III and IV melanoma.
@nl
P2093
P2860
P1433
P1476
Melanogenesis affects overall ...... ith stage III and IV melanoma.
@en
P2093
Andrzej T Slominski
Anna A Brożyna
J Andrew Carlson
Wojciech Jóźwicki
P2860
P304
P356
10.1016/J.HUMPATH.2013.02.022
P407
P577
2013-06-19T00:00:00Z